CEO of ScripsAmerica, Bob Schneiderman, commented,
Post# of 7769
Posted On: 02/12/2015 10:20:38 PM
Re: celtics2014 #6443
CEO of ScripsAmerica, Bob Schneiderman, commented, "PIMD's growth is a very positive development for ScripsAmerica as we generate revenue through our sourcing agreement with the company for pharmaceuticals and medical supplies. Driving sales for PIMD are our new product offerings. We expect revenue generated by our pharmaceutical wholesaler and distributor to continue this growth pattern in the coming months, ultimately increasing ScripsAmerica's shareholder value."
(0)
(0)ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼